Porphyria Cutanea Tarda Unknown Status Phase 2 Trials for Deferasirox (DB01609)

Also known as: Cutanea porphyria tarda / Cutaneous hepatic porphyria / PCT / Porphyria non-acute

IndicationStatusPhase
DBCOND0000759 (Porphyria Cutanea Tarda)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01284946Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea TardaTreatment